Main Industry
Biotechnology
Main Product/Service
EliteCell’s product portfolio includes the “EliteGro™” human‑platelet‑lysate (hPL) line—animal‑serum‑free and xenogeneic‑free cell‑culture supplements for research and commercial cell‑expansion applications; the “EL837” serum‑free lymphocyte culture mediu
Founded Year
2017
Unified Business No.
55627837
Status
Active
Number of Employees
0
Total Paid-in
Capital
3,354,480 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Biomedical EliteCell Corp. focuses on providing safe and effective cell‑culture products for the cell‑therapy industry and research community. With over a decade of cGMP manufacturing experience in the cell supplement market, the company collaborates with USA FDA‑licensed and AABB‑accredited blood centers to ensure 100 % raw‑material traceability. Its Texas‑based cGMP‑compliant facility features an integrated quality‑management system and operates under FDA 21 CFR Part 820 regulations.
